IRIS
LUGHEZZANI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.702
AS - Asia 8.945
EU - Europa 3.428
SA - Sud America 2.054
AF - Africa 512
Continente sconosciuto - Info sul continente non disponibili 378
OC - Oceania 22
Totale 29.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.360
SG - Singapore 5.418
BR - Brasile 1.678
CN - Cina 1.436
IT - Italia 1.191
VN - Vietnam 1.012
FI - Finlandia 493
IE - Irlanda 386
NG - Nigeria 327
DE - Germania 314
FR - Francia 258
HK - Hong Kong 245
GB - Regno Unito 193
CA - Canada 188
AR - Argentina 151
IN - India 140
NL - Olanda 123
TR - Turchia 113
BD - Bangladesh 104
SE - Svezia 89
RU - Federazione Russa 83
MX - Messico 81
ID - Indonesia 67
EC - Ecuador 59
IQ - Iraq 58
JP - Giappone 56
ZA - Sudafrica 53
UA - Ucraina 44
CL - Cile 41
VE - Venezuela 38
ES - Italia 36
IL - Israele 33
CO - Colombia 32
PL - Polonia 32
SA - Arabia Saudita 29
PH - Filippine 28
EG - Egitto 27
PK - Pakistan 27
PY - Paraguay 27
UZ - Uzbekistan 25
AU - Australia 22
DZ - Algeria 22
KE - Kenya 22
RO - Romania 21
MA - Marocco 20
MK - Macedonia 20
BE - Belgio 19
MY - Malesia 19
NP - Nepal 19
CZ - Repubblica Ceca 17
JO - Giordania 16
AT - Austria 14
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
KZ - Kazakistan 12
TN - Tunisia 12
TT - Trinidad e Tobago 12
TW - Taiwan 12
UY - Uruguay 11
DO - Repubblica Dominicana 10
HN - Honduras 10
JM - Giamaica 10
PE - Perù 10
A2 - ???statistics.table.value.countryCode.A2??? 9
LT - Lituania 9
PT - Portogallo 9
GR - Grecia 8
IR - Iran 8
MO - Macao, regione amministrativa speciale della Cina 8
AZ - Azerbaigian 7
ET - Etiopia 7
LB - Libano 7
PS - Palestinian Territory 7
AL - Albania 6
BO - Bolivia 6
HU - Ungheria 6
TH - Thailandia 6
AO - Angola 5
CG - Congo 5
CR - Costa Rica 5
MD - Moldavia 5
PA - Panama 5
RS - Serbia 5
BG - Bulgaria 4
DK - Danimarca 4
GT - Guatemala 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
EU - Europa 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LV - Lettonia 3
OM - Oman 3
PR - Porto Rico 3
SV - El Salvador 3
Totale 28.639
Salva come PNG Salva come JPEG
Città #
Singapore 2.407
Wilmington 1.832
Chandler 1.316
Ashburn 895
The Dalles 800
San Mateo 717
Shanghai 606
Milan 577
San Jose 575
Dallas 542
Ann Arbor 512
Helsinki 491
Dublin 384
Princeton 341
Ho Chi Minh City 335
Leawood 330
Lawrence 327
Benin City 325
Beijing 301
New York 287
Hanoi 234
Hong Kong 224
Boardman 222
Paris 195
Santa Clara 195
Los Angeles 190
Fairfield 187
Woodbridge 186
Rome 182
São Paulo 105
Amsterdam 95
London 95
Toronto 82
Buffalo 77
Kocaeli 66
Rio de Janeiro 60
Orem 59
Council Bluffs 55
Da Nang 54
Seattle 53
Figino 51
Haiphong 51
San Diego 43
Columbus 39
Phoenix 39
Belo Horizonte 38
Chicago 38
Norwalk 36
Brasília 34
Brooklyn 33
Naples 31
Falkenstein 30
Campinas 29
Curitiba 29
Philadelphia 29
Montreal 27
Munich 27
Pune 27
Atlanta 26
Charlotte 25
Biên Hòa 23
Frankfurt am Main 23
Mexico City 23
Porto Alegre 23
Tashkent 23
Chennai 22
Johannesburg 22
Manchester 22
Turin 22
Warsaw 22
Salvador 21
Tokyo 21
Nairobi 20
Thái Bình 20
Falls Church 19
Guayaquil 19
Houston 19
Las Vegas 19
New Delhi 19
Boston 18
Guarulhos 18
Pittsburgh 18
Santiago 18
Brussels 17
Cincinnati 17
Hải Dương 17
Moscow 17
Miami 16
Quito 16
Ribeirão Preto 16
Des Moines 15
Dhaka 15
Queens 14
Redmond 14
Takamatsu 14
Amman 13
Bradenton 13
Can Tho 13
Fortaleza 13
Kuala Lumpur 13
Totale 17.925
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 223
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. 192
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 186
Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project. 180
137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project) 163
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 152
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 143
Accuracy of p2PSA and derivatives (%p2PSA and PHI) in predicting prostate cancer in obese men from a multicenter European study 140
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 139
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project 138
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer 136
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 136
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 133
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 133
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 132
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 132
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 130
[Focal therapy and prostate cancer]. 128
Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance 126
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses 123
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 123
Clinical and pathological predictors of persistent T1 HG at second resection 122
An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men 122
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature. 120
Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis 115
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 113
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 113
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 113
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review 111
[The added value of robotic surgery]. 111
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) REPLY 110
Re: Guazzoni et al.: Oncologic Results of Laparoscopic Renal Cryoablation for Clinical T1a Tumors: 8 Years of Experience in a Single Institution (Urology 2010; 76: 624-629) Reply 107
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination 107
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence 107
HOW TO SIMPLIFY PATIENT POSITIONING AND PORT PLACEMENT DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) 106
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 105
A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States 105
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma REPLY 104
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 103
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma 103
DIAGNOSTIC ACCURACY OF [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER 102
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma 102
Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study 100
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients 99
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting 98
ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 98
IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 98
A POPULATION-BASED ANALYSIS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA 98
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study. 98
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 98
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions 96
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) 96
Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? 96
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 94
Highly-trained dogs' olfactory system for detecting biochemical recurrence following radical prostatectomy 94
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project 94
Robot-assisted laparoscopic partial nephrectomy with Alf–X Robot on pig model 94
Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study 94
A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma 93
The Management of Small Renal Masses: Renal Anatomy and Physiology 93
Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature 92
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 92
INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION 92
Predicting Cancer-specific Mortality After Radical Prostatectomy: Still a Long Way To Go 91
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE 91
Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar 91
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guerin: experience of a single center 91
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer 90
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 89
POPULATION-BASED COMPARISON OF CANCER SPECIFIC MORTALITY AFTER LOCAL TUMOR ABLATION OR NON-ACTIVE TREATMENT FOR T1A KIDNEY CANCER: A COMPETING RISK ANALYSIS 89
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 89
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolo Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.022 89
Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. 89
Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses 88
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 88
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 88
A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma 88
Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target 87
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 86
Is Robotic Surgery Unnecessary for Adrenalectomy? Weighting the Pros and Cons of the Robotic Approach 86
Robot-assisted, Single-site, Dismembered Pyeloplasty for Ureteropelvic Junction Obstruction with the New da Vinci Platform: A Stage 2a Study 86
How Should We Report Incontinence After Radical Prostatectomy? 85
MIDDLE TERM FOLLOW-UP RESULTS OF MAGNETIC RESONANCE IMAGING EVALUATION AFTER FOCAL THERAPY FOR PROSTATE CANCER 85
P2PSA AND DERIVATIVES (% P2PSA AND PHI) ACCURATELY PREDICT PROSTATE CANCER IN OBESE MEN FROM A MULTICENTER PROSPECTIVE EUROPEAN STUDY 85
Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study 85
Serum Index Test %[-2]proPSA and Prostate Health Index are More Accurate than Prostate Specific Antigen and %fPSA in Predicting a Positive Repeat Prostate Biopsy 84
Preoperative Pelvic Floor Muscle Exercise for Early Continence After Radical Prostatectomy: A Randomised Controlled Study 84
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 84
Nephron-sparing Surgery Is Equally Effective to Radical Nephrectomy for T1BN0M0 Renal Cell Carcinoma: A Population-based Assessment 84
Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged < 60 years: results from a multicentric European study 84
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience 84
Population-Based External Validation of a Competing-Risks Nomogram for Patients With Localized Renal Cell Carcinoma 83
Should Bladder Cuff Excision Remain the Standard of Care at Nephroureterectomy in Patients with Urothelial Carcinoma of the Renal Pelvis? A Population-based Study 83
INTRAFASCIAL TECHNIQUE OFFERS IMPROVED FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH BILATERAL NERVE SPARING ROBOTIC RADICAL PROSTATECTOMY 82
UROLOGIST LEARNING CURVE HAS AN IMPACT ON INCREASING PROBABILITY OF CLINICALLY SIGNIFICANT CANCER DETECTION RATE AT MPMRI-TRUS FUSION TARGET BIOPSY: A PROSPECTIVE STUDY IN A SINGLE HIGH VOLUME INSTITUTION 82
The Surgical Learning Curve for One-stage Anterior Urethroplasty: A Prospective Single-surgeon Study 82
Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy 82
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 82
Location of the Primary Tumor is Not an Independent Predictor of Cancer Specific Mortality in Patients With Upper Urinary Tract Urothelial Carcinoma 82
Limited Prognostic Value of Tumor Necrosis in Patients With Renal Cell Carcinoma 82
Totale 10.576
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.622 0 39 32 367 17 21 48 254 151 210 426 57
2022/20234.002 723 118 403 404 381 311 16 292 671 381 259 43
2023/20242.286 184 266 446 117 63 204 141 174 39 42 232 378
2024/20254.174 90 79 48 71 118 422 192 456 599 1.012 473 614
2025/202611.675 1.431 609 833 1.388 354 437 3.009 686 651 777 508 992
2026/20271.699 1.353 346 0 0 0 0 0 0 0 0 0 0
Totale 29.041